Atrophic glossitis is a clinical condition characterized by the loss of lingual papillae, resulting in a smooth, glossy, and often erythematous tongue surface. It is frequently associated with underlying systemic conditions, particularly nutritional deficiencies such as iron, vitamin B12, and folate deficiency, as well as chronic diseases and autoimmune disorders. Patients typically present with tongue discomfort, burning sensation, altered taste, and difficulty in eating. Early recognition is crucial, as atrophic glossitis often serves as a clinical marker of systemic disease. This case report describes a 35-year-old female presenting with symptomatic atrophic glossitis secondary to vitamin B12 deficiency. It highlights the clinical features, diagnostic approach, management, and favorable outcome following targeted therapy.
Atrophic glossitis, also referred to as “bald tongue,” is characterized by partial or complete atrophy of the filiform and fungiform papillae, leading to a smooth and shiny appearance of the tongue. The condition is not a disease entity in itself but rather a manifestation of underlying systemic or local pathology.
Common etiologies include nutritional deficiencies (iron, vitamin B12, folate), chronic infections, autoimmune conditions such as Sjögren’s syndrome, and systemic illnesses like celiac disease. In many cases, atrophic glossitis may be the first visible sign of an underlying deficiency state, particularly megaloblastic anemia.
The condition can significantly impact quality of life due to associated symptoms such as burning sensation (glossodynia), dysgeusia, and oral discomfort. Therefore, identifying the underlying cause is essential for appropriate management and prevention of complications.
Patient History
A 35-year-old female presented to the outpatient department with complaints of a persistent burning sensation of the tongue for the past 2 months. The patient also reported increased sensitivity to spicy foods, altered taste perception, and difficulty in consuming hot beverages.

She noticed a gradual change in the appearance of her tongue, which had become smooth and reddish over time. There was associated fatigue, generalized weakness, and occasional dizziness. No history of fever, oral ulcers, or recent infections was reported.
Her dietary history revealed a strict vegetarian diet for several years. There was no history of alcohol consumption, tobacco use, or recent medication intake. She had no known chronic illnesses or prior similar episodes.
General Examination
Oral Examination
Vital Signs
The absence of white plaques, ulceration, or migratory lesions, along with systemic symptoms, favored a nutritional etiology.
Laboratory Findings
Atrophic glossitis secondary to vitamin B12 deficiency (megaloblastic anemia)

Treatment Plan

Nutritional Therapy
Dietary Counseling
Symptomatic Management
After 2 Weeks
After 1 Month
After 3 Months

The patient remained asymptomatic on follow-up with continued nutritional supplementation.
Atrophic glossitis is an important clinical sign that frequently reflects an underlying systemic disorder, most commonly nutritional deficiencies. Among these, vitamin B12 deficiency is a well-recognized and clinically significant cause, leading to impaired DNA synthesis, ineffective epithelial regeneration, and subsequent mucosal atrophy. Deficiencies of iron and folate may also contribute, either independently or in combination, further disrupting epithelial integrity and accelerating papillary loss. In many patients, atrophic glossitis may precede hematological manifestations, making it an early and valuable diagnostic clue for systemic disease.
The tongue epithelium is characterized by rapid cellular turnover, rendering it particularly vulnerable to deficiencies in essential nutrients required for cell proliferation and maturation. As a result, depletion of these nutrients leads to progressive atrophy of the filiform and fungiform papillae, producing the classic smooth, glossy, and erythematous appearance of the tongue. This structural change is often accompanied by symptoms such as burning sensation, pain, and altered taste perception. Additionally, chronic mucosal atrophy may increase susceptibility to secondary infections and further exacerbate oral discomfort, underscoring the importance of early identification and targeted management.
Pathophysiology
The development of atrophic glossitis in vitamin B12 deficiency involves:
Risk Factors
Clinical Features

Step 1: Clinical Recognition
Step 2: Laboratory Evaluation
Step 3: Exclusion of Other Causes
Etiological Treatment
Supportive Care
Long-Term Monitoring
If Untreated:
Atrophic glossitis is a clinically significant condition that often serves as an early indicator of systemic nutritional deficiencies, particularly vitamin B12 deficiency. This case highlights the importance of thorough clinical examination and targeted investigations in identifying the underlying cause.
Prompt treatment with vitamin supplementation leads to rapid resolution of symptoms and prevents potential complications. Clinicians should maintain a high index of suspicion when evaluating patients with oral mucosal changes, as early intervention ensures optimal outcomes and improved quality of life.
Read more such content on @ Hidoc Dr | Medical Learning App for Doctors
1.
Breast Cancer Patients Living Longer Post-Medicaid Expansion
2.
Error on the MGUS-Autoimmune Disease Association.
3.
Patients with chronic myeloid leukemia who take nilotinib are at higher risk for diabetes and hyperlipidemia.
4.
The majority of cancer medications that receive expedited approval end up failing confirmatory trials.
5.
Unified Neuro/Psych Residency Program: New Proposal.
1.
Optimizing Melanoma Treatment: Strategies in Diagnosis, Clinical Research, and Physician Training
2.
Hemoglobin C: Understanding its Role in Sickle Cell Disease
3.
Beyond the Human Eye: How AI Is Redefining Brain Cancer Diagnosis Through Advanced Imaging
4.
Understanding Abemaciclib: A Breakthrough Treatment for Breast Cancer
5.
The Growing Challenge of Haematological Malignancies in Older Adults
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part II
2.
Exploring Potentials of Lorlatinib: The Third Generation ALK-TKI Through CROWN Trial
3.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VII
4.
A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC
5.
Efficient Management of First line ALK-rearranged NSCLC - Part VI
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation